X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1430) 1430
humans (1387) 1387
animals (899) 899
male (855) 855
female (845) 845
angiogenesis (613) 613
middle aged (556) 556
microvessels - pathology (488) 488
adult (450) 450
mice (445) 445
microvessel density (436) 436
aged (418) 418
immunohistochemistry (414) 414
expression (355) 355
immunology (348) 348
oncology (344) 344
medicine (339) 339
cancer (334) 334
microvessels - metabolism (316) 316
research article (315) 315
endothelium (298) 298
multidisciplinary sciences (292) 292
science (274) 274
prognosis (269) 269
cell biology (267) 267
inflammation (267) 267
pathology (265) 265
analysis (263) 263
microvasculature (263) 263
research (257) 257
vascular endothelial growth factor (248) 248
endothelial growth-factor (239) 239
rats (236) 236
microvessels (234) 234
tumors (233) 233
endothelial cells (228) 228
microvessels - drug effects (223) 223
cells, cultured (212) 212
endothelial cells - metabolism (212) 212
metastasis (199) 199
rodents (199) 199
aged, 80 and over (184) 184
proteins (182) 182
microvessels - immunology (176) 176
cells (175) 175
biology (172) 172
microvessels - physiopathology (170) 170
neovascularization, pathologic - pathology (168) 168
physiological aspects (166) 166
mice, inbred c57bl (161) 161
tumor angiogenesis (159) 159
microcirculation (158) 158
microvessels - cytology (157) 157
gene expression (155) 155
in-vivo (154) 154
carcinoma (152) 152
health aspects (149) 149
article (147) 147
apoptosis (143) 143
endothelial-cells (139) 139
hematology (139) 139
development and progression (137) 137
neurosciences (137) 137
care and treatment (133) 133
blood vessels (132) 132
activation (131) 131
surgery (131) 131
risk factors (128) 128
studies (125) 125
permeability (124) 124
disease models, animal (123) 123
physiology (123) 123
medicine & public health (122) 122
survival (122) 122
time factors (120) 120
biochemistry & molecular biology (119) 119
signal transduction (119) 119
brain (118) 118
endocrinology & metabolism (116) 116
endothelial cells - drug effects (115) 115
medical research (112) 112
medicine, research & experimental (109) 109
brain - blood supply (108) 108
neovascularization (107) 107
in-vitro (106) 106
neovascularization, pathologic (106) 106
blood-brain barrier (105) 105
cell proliferation (103) 103
blood (101) 101
cell line, tumor (101) 101
diabetes (100) 100
endothelium, vascular - metabolism (100) 100
neovascularization, pathologic - metabolism (100) 100
young adult (98) 98
vascular endothelial growth factor a - metabolism (96) 96
breast cancer (95) 95
cytokines (95) 95
disease (94) 94
microvessels - physiology (92) 92
biomedicine (91) 91
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Immunology, ISSN 0022-1767, 10/2009, Volume 183, Issue 8, pp. 5244 - 5250
Journal Article
Diabetes, ISSN 0012-1797, 09/2018, Volume 67, Issue 9, pp. 1867 - 1879
Intermittent fasting (IF) protects against the development of metabolic diseases and cancer, but whether it can prevent diabetic microvascular complications is... 
DIABETIC-RETINOPATHY | BILE-ACID | CELLS | ACTIVATION | BACTERIA | OBESITY | METABOLISM | FARNESOID X RECEPTOR | C57BL/6 MICE | ENDOCRINOLOGY & METABOLISM | TAUROURSODEOXYCHOLIC ACID | Retina - drug effects | Leukocytes - pathology | Receptors, G-Protein-Coupled - metabolism | Colon - drug effects | Microvessels - metabolism | Microvessels - pathology | Colon - immunology | Male | Ganglia, Sensory - metabolism | Retina - immunology | Intestinal Mucosa - drug effects | Diabetic Retinopathy - complications | Retinal Vessels - pathology | Feces - microbiology | Intestinal Mucosa - immunology | Bacteroidetes - isolation & purification | Firmicutes - growth & development | Diabetic Retinopathy - immunology | Firmicutes - isolation & purification | Retinal Vessels - metabolism | Colon - pathology | Retinal Vessels - drug effects | Dysbiosis - therapy | Goblet Cells - metabolism | Colon - metabolism | Ganglia, Sensory - pathology | Diabetic Retinopathy - prevention & control | Gastrointestinal Microbiome - drug effects | Bile Acids and Salts - therapeutic use | Survival Analysis | Leukocytes - drug effects | Diabetes Mellitus, Type 2 - pathology | Dysbiosis - pathology | Retina - pathology | Intestinal Mucosa - pathology | Intestinal Mucosa - metabolism | Retina - metabolism | Diabetes Mellitus, Type 2 - microbiology | Ganglia, Sensory - drug effects | Goblet Cells - drug effects | Diabetic Retinopathy - pathology | Receptors, G-Protein-Coupled - agonists | Dysbiosis - microbiology | Microvessels - immunology | Ganglia, Sensory - immunology | Goblet Cells - immunology | Leukocytes - immunology | Retinal Vessels - immunology | Mice, Mutant Strains | Diabetes Mellitus, Type 2 - therapy | Bacteroidetes - immunology | Mice, Inbred DBA | Verrucomicrobia - growth & development | Verrucomicrobia - immunology | Diabetes Mellitus, Type 2 - complications | Fasting | Microvessels - drug effects | Firmicutes - immunology | Verrucomicrobia - isolation & purification | Dysbiosis - complications | Animals | Bacteroidetes - growth & development | Gastrointestinal Microbiome - immunology | Goblet Cells - pathology | Prevention | Diabetic retinopathy | Usage | Diet therapy | Low-calorie diet | Rattus | Rats | Health aspects | Complications | 0107
Journal Article
FASEB Journal, ISSN 0892-6638, 04/2010, Volume 24, Issue 4, pp. 1023 - 1034
Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to... 
Neuroinflammation | Multiple sclerosis | Reactive oxygen species | LIGHT-CHAIN KINASE | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | MULTIPLE-SCLEROSIS LESIONS | multiple sclerosis | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROVESSEL ENDOTHELIAL-CELLS | T-CELL | SPHINGOSINE 1-PHOSPHATE | FREE-RADICALS | CELL BIOLOGY | MEDICAL PROGRESS | neuroinflammation | reactive oxygen species | IL-17 | BIOLOGY | CENTRAL-NERVOUS-SYSTEM | Reactive Oxygen Species - metabolism | Encephalomyelitis, Autoimmune, Experimental - metabolism | Interleukin-17 - immunology | NADPH Oxidases - metabolism | Oxidative Stress - immunology | Encephalomyelitis, Autoimmune, Experimental - immunology | NADPH Oxidases - immunology | Interleukin-17 - pharmacology | Occludin | Antibodies, Neutralizing - immunology | Reactive Oxygen Species - immunology | T-Lymphocytes, Helper-Inducer - immunology | Membrane Proteins - metabolism | T-Lymphocytes, Helper-Inducer - pathology | Xanthine Oxidase - metabolism | Blood-Brain Barrier - immunology | Myosin-Light-Chain Kinase | Encephalomyelitis, Autoimmune, Experimental - pathology | T-Lymphocytes, Helper-Inducer - metabolism | Endothelial Cells - metabolism | Enzyme Inhibitors - pharmacology | Antibodies, Neutralizing - pharmacology | Membrane Proteins - immunology | Xanthine Oxidase - immunology | Down-Regulation - drug effects | Blood-Brain Barrier - metabolism | Naphthalenes - pharmacology | Azepines - pharmacology | Endothelial Cells - immunology | Blood-Brain Barrier - pathology | Interleukin-17 - metabolism | Animals | Interleukin-17 - antagonists & inhibitors | Down-Regulation - immunology | Mice | Mice, Inbred BALB C | Oxidative Stress - drug effects | Endothelial Cells - pathology | Cell Line, Transformed
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 12/2016, Volume 5, Issue 12, p. n/a
Journal Article
Cancer Cell, ISSN 1535-6108, 2011, Volume 19, Issue 1, pp. 31 - 44
Polarization of tumor-associated macrophages (TAMs) to a proangiogenic/immune-suppressive (M2-like) phenotype and abnormal, hypoperfused vessels are hallmarks... 
Clodronic Acid - pharmacology | Gene Expression - genetics | Dendritic Cells - immunology | Humans | Pregnancy Proteins - genetics | Microvessels - pathology | Pregnancy Proteins - metabolism | Chemotactic Factors - metabolism | Neoplasm Metastasis - immunology | Antibodies - immunology | Neovascularization, Pathologic - immunology | Macrophages, Peritoneal - drug effects | Macrophages - pathology | Neoplasms - blood supply | Down-Regulation - genetics | Mice, Knockout | Macrophages - metabolism | Neoplasms - immunology | Cell Line, Tumor | Placenta Growth Factor | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Macrophages, Peritoneal - metabolism | Neoplasms - metabolism | CD8-Positive T-Lymphocytes - pathology | Gene Expression - drug effects | Regional Blood Flow - genetics | Dendritic Cells - pathology | Culture Media, Conditioned - pharmacology | Lung Neoplasms - pathology | Hypoxia - metabolism | Neovascularization, Pathologic - pathology | Regional Blood Flow - drug effects | Transfection | Lung Neoplasms - secondary | Neoplasms - genetics | Dendritic Cells - metabolism | Macrophages - immunology | Lung Neoplasms - genetics | Microvessels - ultrastructure | Cytokines - metabolism | Mice, Inbred C57BL | Microvessels - drug effects | Pregnancy Proteins - immunology | Antibodies - pharmacology | Proteins - genetics | Neoplasm Metastasis - genetics | Hypoxia - genetics | Lung Neoplasms - immunology | Animals | Proteins - metabolism | Endothelial Cells - cytology | Neoplasm Metastasis - pathology | Macrophages - drug effects | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Proteins - pharmacology | Neoplasms - pathology | Endothelial Cells - drug effects
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 559 - 15
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e54923
There is increasing experimental evidence for an important role of Angiopoietin-2 (Ang-2) in tumor angiogenesis and progression. In addition, Ang-2 is... 
ENDOTHELIAL-CELL SURVIVAL | ADVANCED SOLID TUMORS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | BLOOD-VESSELS | OCULAR ANGIOGENESIS | OVARIAN-CANCER | ANTITUMOR-ACTIVITY | AMG 386 | SHORT-TERM | TIE2 RECEPTOR | Antibody Specificity | Phosphorylation | Colonic Neoplasms - drug therapy | Humans | Cornea - immunology | Microvessels - immunology | Angiopoietin-1 - immunology | Angiopoietin-2 - immunology | Antibodies, Neutralizing - immunology | Cornea - drug effects | Colonic Neoplasms - immunology | HEK293 Cells | Female | Antineoplastic Agents - pharmacology | Neovascularization, Pathologic - immunology | Receptor, TIE-2 - antagonists & inhibitors | Colonic Neoplasms - blood supply | Antineoplastic Agents - immunology | Microvessels - drug effects | Antibodies, Neutralizing - pharmacology | Random Allocation | Receptor, TIE-2 - immunology | Mice, SCID | Angiopoietin-1 - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Angiopoietin-2 - antagonists & inhibitors | Viral antibodies | Antimitotic agents | Complications and side effects | Antibodies | Physiological aspects | Comparative analysis | Antineoplastic agents | Animal models | Angiopoietin | Leukemia | Oncology | Smooth muscle | Selectivity | Arthritis | Metastasis | Angiogenesis | Physiology | Inhibition | Trachea | Immunoglobulins | Tumor cells | Blood vessels | Pharmacology | Breast cancer | Chemical compounds | Lungs | Antiangiogenics | Ligands | Cancer | Tumors
Journal Article